Search results for "Refractory"

showing 10 items of 253 documents

REMOVAL OF AN ORGANIC REFRACTORY COMPOUND BY PHOTOCATALYSIS IN BATCH REACTOR - KINETIC STUDIES

2015

Environmental EngineeringChemical engineeringChemistryBatch reactorPhotocatalysisManagement Monitoring Policy and LawPollutionRefractory (planetary science)Environmental Engineering and Management Journal
researchProduct

Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Ef…

2021

Objective Eribulin mesylate (EM) is a fully synthetic macrocyclic ketone analogue of the marine natural product halichondrin. EM has been reported to be active in metastatic breast cancer. In this paper, we report efficacy and safety of data of EM in a retrospective, real-world series of patients with poor prognosis, hormone-refractory, or triple-negative metastatic breast cancer. Materials and methods The analysis was carried out at 4 interrelated oncology centers. EM was delivered at the dose of 1.4 mg/m2 in 100 mL of normal saline over 2 to 5 minutes on days 1 and 8 every 21 days. EM was continued until disease progression or unacceptable toxicity. Side effects were reported every cycle …

Eribulin MesylateOncologyAdultCancer Researchmedicine.medical_specialtyNeoplasms Hormone-Dependenteribulin mesylateSettore MED/06 - Oncologia Medicamedicine.medical_treatmentAntineoplastic AgentsTriple Negative Breast Neoplasmstriple negative03 medical and health sciences0302 clinical medicineStable DiseaseBreast cancerbreast cancerInternal medicineAntineoplastic Combined Chemotherapy Protocolshormonal refractorymedicineHumans030212 general & internal medicineFuransSalineTriple-negative breast cancerAgedRetrospective StudiesChemotherapybusiness.industryKetonesMiddle Agedmedicine.diseaseMetastatic breast cancerSettore MED/18 - Chirurgia GeneraleTreatment OutcomeOncology030220 oncology & carcinogenesisToxicityFemalebusiness
researchProduct

Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors.

2022

Background: A subset of patients with metastatic renal cell carcinoma (mRCC), deemed as primary refractory, shows progressive disease as the best response to first-line therapy even when treated with novel immune-based combos. Objective: We aimed to assess the outcome of patients treated with second-line cabozantinib for mRCC primary refractory to first-line therapy defined as Response Evaluation Criteria in Solid Tumors (RECIST) progression in the computed tomography scan as the best response to the upfront treatment. Design, setting, and participants: We retrospectively collected data from 11 worldwide centers. Outcome measurements and statistical analysis: Overall survival (OS) and progr…

First lineSecond linePrimary refractorySettore MED/06 - Oncologia MedicaUrologyCabozantinibRenal cell carcinomaEuropean urology focus
researchProduct

Screening for multiple hereditary hypercoagulability factors using the amplification refractory mutation system

2003

Many hereditary factors have been implicated in the development of arterial and/or venous thromboembolic diseases. A number of these risk factors can be identified by the amplification refractory mutation system (ARMS). However, the underlying technical conditions for performing ARMS are highly variable, and depend on which risk factors are being analyzed. We have now developed a novel ARMS-based system to simultaneously screen for multiple hypercoagulability factors under identical PCR conditions. This can greatly simplify the process of screening for hereditary hypercoagulability.

GeneticsBase SequenceGenetic Carrier ScreeningHomozygoteGenetic Carrier ScreeningSingle-strand conformation polymorphismBlood ProteinsHematologyBlood Coagulation DisordersBiologymedicine.diseaseThrombophiliaBioinformaticsPolymerase Chain ReactionThrombosisBlood Coagulation FactorsRefractoryMutation (genetic algorithm)medicineCoagulopathyHumansMass ScreeningRisk factorDNA PrimersThrombosis Research
researchProduct

Analyzing the electrophysiological effects of local epicardial temperature in experimental studies with isolated hearts

2008

As a result of their modulating effects upon myocardial electrophysiology, both hypo- and hyperthermia can be used to study the mechanisms that generate or sustain cardiac arrhythmias. The present study describes an original electrode developed with thick-film technology and capable of controlling regional temperature variations in the epicardium while simultaneously registering its electrical activity. In this way, it is possible to measure electrophysiological parameters of the heart at different temperatures. The results obtained with this device in a study with isolated and perfused rabbit hearts are reported. An exploration has been made of the effects of local temperature changes upon…

Hyperthermiamedicine.medical_specialtyRefractory Period ElectrophysiologicalPhysiologyRefractory periodBiomedical EngineeringBiophysicsIn Vitro TechniquesNerve conduction velocityBody TemperaturePhysiology (medical)Internal medicinemedicineAnimalsChemistryHeartmedicine.diseaseCardiovascular physiologyElectrophysiologyVentricular activationVentricular FibrillationVentricular fibrillationCardiologyRabbitsPericardiumBiomedical engineeringPhysiological Measurement
researchProduct

Clinical and Biological Characterization of Patients with Low/Intermediate-1 Risk Myelodysplastic Syndrome and Iron Overload

2012

Abstract Abstract 4956 Introduction. Patients with Myelodysplastic Syndrome (MDS) are susceptible to developing iron overload as a response to the red blood cell (RBC) transfusions and ineffective hematopoiesis. This iron overload (IOL) is characterized by an increase in oxygen-reactive species accompanied by a decrease in antioxidants, and results in hepatic, cardiac and endocrine disorders, as well as an increased risk of infection. Ineffective hematopoiesis promotes iron absorption at intestinal level. This process is enhanced by the presence of mutations in the hereditary hemochromatosis gene (HFE). This study aims to define the features that accompany patients with iron overload, compa…

Ineffective Hematopoiesismedicine.medical_specialtyPathologyLiver Iron Concentrationeducation.field_of_studybiologybusiness.industryImmunologyPopulationCell BiologyHematologyBiochemistryGastroenterologyRed blood cellmedicine.anatomical_structureAlanine transaminaseRefractory sideroblastic anemiaInternal medicineHereditary hemochromatosismedicinebiology.proteinChelation therapybusinesseducation
researchProduct

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.

2007

Abstract The increasing evidence that γδ T cells have potent antitumor activity suggests their value in immunotherapy, particularly in areas of unmet need such as metastatic carcinoma. To this end, we initiated a phase I clinical trial in metastatic hormone-refractory prostate cancer to examine the feasibility and consequences of using the γδ T-cell agonist zoledronate, either alone or in combination with low-dose interleukin 2 (IL-2), to activate peripheral blood γδ cells. Nine patients were enlisted to each arm. Neither treatment showed appreciable toxicity. Most patients were treated with zoledronate + IL-2, but conversely only two treated with zoledronate displayed a significant long-te…

Interleukin 2MaleCancer ResearchNeoplasms Hormone-Dependentmedicine.medical_treatmentT cellT-LymphocytesAntineoplastic AgentsLymphocyte ActivationZoledronic AcidArticleMetastatic carcinomaProstate cancerAntigenMedicineHumansAgedAged 80 and overSalvage TherapyBone Density Conservation AgentsDiphosphonatesDose-Response Relationship Drugbusiness.industryRemission InductionImidazolesProstatic NeoplasmsReceptors Antigen T-Cell gamma-deltaImmunotherapyMiddle Agedmedicine.diseaseVγ9Vδ2 T cellsZoledronateIL-2Hormone-refractory prostate cancerImmunotherapyCytokinemedicine.anatomical_structureTreatment OutcomeOncologyImmunologyFeasibility StudiesInterleukin-2Tumor necrosis factor alphaDrug Therapy CombinationImmunotherapybusinessmedicine.drug
researchProduct

Comparison of subconjunctival microinvasive glaucoma surgery and trabeculectomy

2021

Purpose To assess surgical success and the post-operative development of intraocular pressure between XEN45® gelstent, Preserflo® MicroShunt and trabeculectomy with mitomycin C. Methods Data from 105 eyes from 105 patients of matched cases with refractory open-angle glaucoma, who underwent surgery between January 2019, and August 2020, were evaluated. Patients underwent either stand-alone XEN gelstent insertion with Mitomycin C, stand-alone Preserflo with Mitomycin C or trabeculectomy with Mitomycin C. The primary outcome was the proportion of complete surgical success at 6 months post-operatively (i.e. intraocular pressure between 5mmHg and 18mmHg, no revision surgery, no loss of light per…

Intraocular pressuremedicine.medical_specialtyVisual acuitygenetic structuresMitomycinmedicine.medical_treatment610 MedizinGlaucomaTrabeculectomyAstigmatismTonometry OcularRefractory610 Medical sciencesOphthalmologymedicineGlaucoma surgeryHumansTrabeculectomyIntraocular PressureRetrospective Studiesbusiness.industryMitomycin CGeneral Medicinemedicine.diseaseOphthalmologyTreatment Outcomemedicine.symptombusinessGlaucoma Open-AngleFollow-Up StudiesActa Ophthalmologica
researchProduct

Effects of chronic exercise on myocardial refractoriness: a study on isolated rabbit heart

2008

Aim:  To determine whether chronic physical training increases atrial and ventricular refractoriness in isolated rabbit heart. Methods:  Trained rabbits were submitted to a protocol of treadmill running. The electrophysiological parameters of refractoriness investigated in an isolated heart preparation were: (1) atrial effective refractory period (AERP) and atrial functional refractory period and ventricular effective and functional refractory periods (VERP and VFRP) using the extrastimulus technique at four different pacing cycle lengths; (2) the dominant frequency (DF) of ventricular fibrillation (VF). A multi-electrode plaque containing 256 electrodes and a spectral method were used to o…

Isolated Heart Preparationmedicine.medical_specialtyRefractory Period ElectrophysiologicalPhysiologyRefractory periodNitric Oxide Synthase Type IIPhysical exerciseMotor ActivityOrgan Culture TechniquesHeart RatePhysical Conditioning AnimalInternal medicineHeart ratemedicineAnimalsVentricular FunctionLagomorphabiologybusiness.industryMyocardiumHeartChaperonin 60Organ SizeAtrial Functionbiology.organism_classificationmedicine.diseaseSurgeryElectrophysiologyVentricular FibrillationVentricular fibrillationCirculatory systemcardiovascular systemCardiologyRabbitsbusinessActa Physiologica
researchProduct

Laser spectroscopy of radioactive Ti, Zr and Hf isotopes and isomers at the JYFL laser-IGISOL facility

2003

Abstract The recent progress at the laser-ion guide isotope separator on-line facility, JYFL, is presented. At the facility new techniques for studying short-lived radioisotopes by laser spectroscopy have been developed and applied to the study of isotopes in refractory metal elements. In particular, recent results on the spectroscopy of cooled ion beams of radioactive Ti, Zr and Hf isotopes are discussed.

IsotopeChemistryRadiochemistryAnalytical chemistryRefractory metalsLaserAtomic and Molecular Physics and OpticsFluorescence spectroscopyAnalytical ChemistryIonlaw.inventionlawPhysics::Accelerator PhysicsPhysics::Atomic PhysicsNuclear ExperimentSpectroscopyInstrumentationSpectroscopySeparator (electricity)Spectrochimica Acta Part B: Atomic Spectroscopy
researchProduct